Lebanon bans cancer drug

The WHO on Tuesday cited adverse effects in pediatric patients receiving the drug, and said that its product alert referred to a batch of substandard Methothrex (methotrexate), which had been identified in Yemen and Lebanon.

The drug, an immunosuppressant used to treat cancer and autoimmune diseases, is on the WHO model list of essential medicines.

“It is important to detect and remove this contaminated product from circulation to prevent harm to patients,” the WHO alert said.

--

--

I am blessed with a funny gene that makes me enjoy life to the fullest. I love to travel, eat and jog. I write interesting topics in middle east and beyond

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Zachary Weaver

I am blessed with a funny gene that makes me enjoy life to the fullest. I love to travel, eat and jog. I write interesting topics in middle east and beyond